1. Hou, Hong Xiang, Pang, Li, Zhao, Liang, Xing, Jihong. 2024. Ferroptosis-related gene MAPK3 is associated with the neurological outcome after cardiac arrest. In PloS one, 19, e0301647. doi:10.1371/journal.pone.0301647. https://pubmed.ncbi.nlm.nih.gov/38885209/
2. Wang, Nan, Wei, Linfeng, Liu, Die, Ding, Lexi, Xiong, Siqi. 2022. Identification and Validation of Autophagy-Related Genes in Diabetic Retinopathy. In Frontiers in endocrinology, 13, 867600. doi:10.3389/fendo.2022.867600. https://pubmed.ncbi.nlm.nih.gov/35574010/
3. Weng, Jiao, Wu, Xiu-Fang, Shao, Peng, Liu, Xing-Pu, Wang, Cai-Xia. 2024. Medicine for chronic atrophic gastritis: a systematic review, meta- and network pharmacology analysis. In Annals of medicine, 55, 2299352. doi:10.1080/07853890.2023.2299352. https://pubmed.ncbi.nlm.nih.gov/38170849/
4. Kam, Audrey E, Masood, Ashiq, Shroff, Rachna T. . Current and emerging therapies for advanced biliary tract cancers. In The lancet. Gastroenterology & hepatology, 6, 956-969. doi:10.1016/S2468-1253(21)00171-0. https://pubmed.ncbi.nlm.nih.gov/34626563/
5. Devaiah, Ballachanda N, Mu, Jie, Akman, Ben, Levens, David, Singer, Dinah S. 2020. MYC protein stability is negatively regulated by BRD4. In Proceedings of the National Academy of Sciences of the United States of America, 117, 13457-13467. doi:10.1073/pnas.1919507117. https://pubmed.ncbi.nlm.nih.gov/32482868/
6. Li, Xiaoyan, Shen, Aotian, Zhao, Yiran, Xia, Junfeng. . Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders. In Schizophrenia bulletin, 49, 1305-1315. doi:10.1093/schbul/sbad100. https://pubmed.ncbi.nlm.nih.gov/37418754/
7. Hu, Weitao, Chen, Xiaoqing. 2022. Identification of hub ferroptosis-related genes and immune infiltration in lupus nephritis using bioinformatics. In Scientific reports, 12, 18826. doi:10.1038/s41598-022-23730-8. https://pubmed.ncbi.nlm.nih.gov/36335193/
8. Liu, Jiewei, Cheng, Yuqi, Li, Ming, Li, Tao, Luo, Xiong-Jian. 2022. Genome-wide Mendelian randomization identifies actionable novel drug targets for psychiatric disorders. In Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 48, 270-280. doi:10.1038/s41386-022-01456-5. https://pubmed.ncbi.nlm.nih.gov/36114287/